| Mr Jonathan Paul Rohloff, | |
|
4 E Clark Bass Blvd, Suite 300, Mcalester, OK 74501-4269 | |
| (918) 421-6795 | |
| (918) 421-6791 |
| Full Name | Mr Jonathan Paul Rohloff |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 4 E Clark Bass Blvd, Mcalester, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306200548 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 6242 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mcalester Regional Health Center | Mcalester, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcalester Regional Health Center Authority | 6709796436 | 66 |
| Prime Physician Staffing 2 Pllc | 7416292636 | 12 |
| Mcalester Medical Services Llc | 9931139029 | 24 |
News Archive
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
Rite Aid Corporation today reported operating results for its fourth quarter and fiscal year ended March 1, 2014.
A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.
A new study compares neighborhoods' walkability (degree of ease for walking) with local levels of air pollution and finds that some neighborhoods might be good for walking, but have poor air quality. Researchers involved in the study include University of Minnesota faculty member Julian Marshall and University of British Columbia faculty Michael Brauer and Lawrence Frank.
› Verified 7 days ago
| Entity Name | Mcalester Regional Health Center Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316940034 PECOS PAC ID: 6709796436 Enrollment ID: O20040303001042 |
News Archive
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
Rite Aid Corporation today reported operating results for its fourth quarter and fiscal year ended March 1, 2014.
A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.
A new study compares neighborhoods' walkability (degree of ease for walking) with local levels of air pollution and finds that some neighborhoods might be good for walking, but have poor air quality. Researchers involved in the study include University of Minnesota faculty member Julian Marshall and University of British Columbia faculty Michael Brauer and Lawrence Frank.
› Verified 7 days ago
| Entity Name | Mcalester Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317998 PECOS PAC ID: 9931139029 Enrollment ID: O20050818000234 |
News Archive
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
Rite Aid Corporation today reported operating results for its fourth quarter and fiscal year ended March 1, 2014.
A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.
A new study compares neighborhoods' walkability (degree of ease for walking) with local levels of air pollution and finds that some neighborhoods might be good for walking, but have poor air quality. Researchers involved in the study include University of Minnesota faculty member Julian Marshall and University of British Columbia faculty Michael Brauer and Lawrence Frank.
› Verified 7 days ago
| Entity Name | Prime Physician Staffing 2 Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427523109 PECOS PAC ID: 7416292636 Enrollment ID: O20181217001900 |
News Archive
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
Rite Aid Corporation today reported operating results for its fourth quarter and fiscal year ended March 1, 2014.
A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.
A new study compares neighborhoods' walkability (degree of ease for walking) with local levels of air pollution and finds that some neighborhoods might be good for walking, but have poor air quality. Researchers involved in the study include University of Minnesota faculty member Julian Marshall and University of British Columbia faculty Michael Brauer and Lawrence Frank.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jonathan Paul Rohloff, 2259 Green Meadows Cir, Mcalester, OK 74501-3245 Ph: (402) 320-0715 | Mr Jonathan Paul Rohloff, 4 E Clark Bass Blvd, Suite 300, Mcalester, OK 74501-4269 Ph: (918) 421-6795 |
News Archive
Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.
Rite Aid Corporation today reported operating results for its fourth quarter and fiscal year ended March 1, 2014.
A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.
A new study compares neighborhoods' walkability (degree of ease for walking) with local levels of air pollution and finds that some neighborhoods might be good for walking, but have poor air quality. Researchers involved in the study include University of Minnesota faculty member Julian Marshall and University of British Columbia faculty Michael Brauer and Lawrence Frank.
› Verified 7 days ago
Dr. Johnny A Zellmer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3101 Elks Road, Mcalester, OK 74501 Phone: 918-426-2442 Fax: 918-426-0888 | |
Janet H Green, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1401 E Van Buren Ave, Mcalester, OK 74501 Phone: 918-426-0240 Fax: 918-423-4051 | |
William Edwin Gupton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1401 E Van Buren Ave, Mcalester, OK 74501 Phone: 918-426-0240 Fax: 918-423-4051 | |
Kyle A Stilwell, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 S 3rd St, Mcalester, OK 74501 Phone: 918-527-2626 | |
Sarah Elizabeth Sharp, FNP-BC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2206 N Main St, Mcalester, OK 74501 Phone: 918-420-9340 Fax: 918-420-9345 | |
Dr. Jason Adam Mcelyea, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 E Clark Bass Blvd, Mcalester, OK 74501 Phone: 918-421-1800 | |
Dr. Oluwatoke Omotola Omiwade, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1 E Clark Bass Blvd, Mcalester, OK 74501 Phone: 918-421-4689 Fax: 918-421-8990 |